MYLAN 1258 MYLAN 1258 (Propafenone hydrochloride extended-release 225 mg)
Pill imprint MYLAN 1258 MYLAN 1258 has been identified as Propafenone hydrochloride extended-release 225 mg.
Propafenone is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 225 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 1258 MYLAN 1258
- Strength:
- 225 mg
- Color:
- Red & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
More about propafenone
Consumer resources
- Other brands: Rythmol, Rythmol SR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
